Necrotizing pancreatitis: looking back at new frontiers ...

Pancreatic cancer is a highly malignant tumor known for its extremely low survival rate. The combination of genetic disorders within pancreatic cells and the tumor microenvironment contributes to the ...

The American Cancer Society estimates that about 67,440 Americans (34,950 men and 32,490 women) will be diagnosed with pancreatic cancer this year. Of those, about 51,980 people (27,050 men and ...

Pranathi Perati was running out of time to treat her stage-four pancreatic cancer when she found out she would get another shot: a clinical trial testing a new experimental drug. Perati’s odds ...

Mick needs creon since being treated for pancreatic cancer in 2023 Cancer patients and others with debilitating conditions have highlighted shortages of a vital drug they say have had a ...

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of the lower longterm survival rates with only about 13 percent of ...

The new blood-based assay PAC-MANN-1 (protease activity–based cancer marker using magnetic nanosensor-1) identified pancreatic ductal adenocarcinoma (PDAC) across all stages with high ...

Osaka University researchers said Wednesday that they have developed a method to test for pancreatic cancer with pancreatic cells or DNA collected through a modified catheter during gastric ...

Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to come. As few as one in ten people survive pancreatic cancer five years ...